Question Everything Posted: July 13, 2006 As reported in yesterday's Wall Street Journal, "Awaiting approval from U.S. regulators to sell an over-the-counter diet pill called Alli, GlaxoSmithKline PLC has set out to establish itself as an online weight-loss authority, with a Web site that offers dieting tips and collects data and email addresses from consumers who visit." The Web site is Questioneverything.com. I take this as an invitation to me personally to question everything about the site, including its intended audience, its ability to overcome barriers to acceptance of Alli in the marketplace, and its market research vs. positioning goals. For all that and more, see today's post to Pharma Marketing Blog. For more posts in related topic areas, see: eMarketing Public Relations/Image Unbranded Advertising If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe. Enter your Email Address | Return to Pharma Marketing Blog Topics |

Special Supplement ePharma Marketing Many experts believe that pharma eMarketing is at a tipping point and that pharmaceutical companies are poised to shift substantial ad spending from TV and other media to the Internet. The selection of articles in this Special Supplement to Pharma Marketing News was chosen to give you a better perspective on pharma eMarketing. Included are real world case studies that illustrate the advantages of eMarketing such as depth of information, interaction, relationship building and superior customer engagement. TABLE OF CONTENTS Order and pay for this Special Supplement now using your credit card ONLY $29.95 PDF file delivered to you by email (usually within minutes of placing your order): If you wish to pay by check or credit card off-line, please use: Printable Order Form